September 8, 2026
11 °C London, UK

Serving Intelligent Investors

PAREXEL International Corporation (PRXL)

PAREXEL International Corporation (PAREXEL) is a biopharmaceutical services company, providing a range of expertise in clinical research, medical communications, consulting, and advanced technology products and services to the worldwide pharmaceutical, biotechnology, and medical device industries. It operates it three segment Clinical Research Services (CRS), PAREXEL Consulting and Medical Communications Services (PCMS) and Perceptive Informatics, Inc.

Previous Article

CA Technologies (CA) Profile and Research

Next Article

Actavis plc (ACT). Analysis and outlook

You might be interested in …

ARKK ARK Innovation

Morningstar: Why We’ve Downgraded ARK Innovation

ARK Innovation ETF (ARKK) shows few signs of improving its risk management or ability to successfully navigate the challenging territory it explores. Its Morningstar Analyst Rating drops to Negative from Neutral as its People and Parent ratings both drop to Below Average from Average.